Results 1 to 10 of about 37,587 (162)
Brexit – What are the potential consequences for pharma patents and SPCs [PDF]
British Journal of Pharmacy, 2017 Brexit raises a number of difficult questions with regard to intellectual property rights in a post-Brexit world, particularly for UK based pharma companies.
Jamie Fraser, James Stones
doaj +3 more sources
Cross-Border Patent Disputes: Unified Patent Court or International Commercial Arbitration?
Utrecht Journal of International and European Law, 2016 Currently, the enforcement of a patent that is registered in several countries involves the risk of getting different and conflicting decisions from the national courts.
Ana Alba Betancourt
doaj +4 more sources
Revista de Estudios Jurídicos y CriminológicosProtecting research has always been a relevant issue in order to foster innovation, especially in the pharmaceutical field. Intellectual property rights protection plays a main role in the current economy since it allows companies to monetize efforts ...
Pietro Cappabianca
doaj +4 more sources
Social Sciences, 2023 The Unified Patent Court (UPC) will be the pillar of a unified European patent enforcement system. Crucial to its success will be the harmonization of geographical variation in national jurisdictions.
Marius Zipf +5 more
doaj +1 more source
Still Unifying? The Future of the Unified Patent Court [PDF]
IIC - International Review of Intellectual Property and Competition Law, 2021 AbstractSince its launching, the Unified Patent Court (UPC) project has faced obstacles and scepticism from some EU Member States. When the United Kingdom ratified the UPC Agreement in 2018, it seemed that there was nothing left but to wait for a positive decision of the Federal Constitutional Court of Germany on the ratification by that country, so ...
openaire +2 more sources
Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates
British Journal of Pharmacy, 2021 Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little
Harry Melville O'Brien +2 more
doaj +1 more source
Biotechnologies and patent law: The case of European Union
Цифровое право, 2023 The rapid development of biotechnologies requires taking comprehensive steps to actualise and consolidate actions. In order to introduce new technologies into life in the most rapid and appropriate way, it is imperative to establish mechanisms and ...
A. I. Shcherbakova
doaj +1 more source
Impacts of Establishment of Unitary Patent System in European Union [PDF]
Faṣlnāmah-i Pizhūhish-i Huqūq-i ̒Umūmī, 2016 Undoubtedly, one of the most significant changes in the patent system is the recent EU Member States’ agreement on signing and approving the regulations concerning new unitary patent system.
Mehdi Zahedi +2 more
doaj +1 more source
The Unitary Patent Package & Unified Patent Court. Problems, Possible Improvements and Alternatives
, 2023 Published
Desaunettes, Luc +3 more
openaire +4 more sources
A Unitary Patent for a (dis)United Europe and the Long Shadow of History [PDF]
, 2015 This article retraces the history of patent harmonization in Europe and reviews the European Union “patent package” and its approval by the Grand Chamber of the Court of Justice of the European Union in the light of this history.
Plomer, A.
core +4 more sources